We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2pjl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2pjl.gif|left|200px]]
[[Image:2pjl.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2pjl |SIZE=350|CAPTION= <scene name='initialview01'>2pjl</scene>, resolution 2.300&Aring;
+
The line below this paragraph, containing "STRUCTURE_2pjl", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=047:1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE'>047</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE= ESRRA, ERR1, ESRL1, NR3B1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2pjl| PDB=2pjl | SCENE= }}
-
|RELATEDENTRY=[[1xb7|1XB7]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2pjl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2pjl OCA], [http://www.ebi.ac.uk/pdbsum/2pjl PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2pjl RCSB]</span>
+
-
}}
+
'''Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism'''
'''Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism'''
Line 26: Line 23:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Kallen, J.]]
[[Category: Kallen, J.]]
-
[[Category: coactivator groove]]
+
[[Category: Coactivator groove]]
-
[[Category: helix 12 (h12)]]
+
[[Category: Inverse agonist]]
-
[[Category: inverse agonist]]
+
[[Category: Ligand binding domain]]
-
[[Category: ligand binding domain]]
+
[[Category: Ligand binding pocket]]
-
[[Category: ligand binding pocket]]
+
[[Category: Nuclear hormone receptor]]
-
[[Category: nuclear hormone receptor]]
+
[[Category: Three-layered alpha-helical sandwich]]
-
[[Category: three-layered alpha-helical sandwich]]
+
[[Category: Transcription]]
-
[[Category: transcription]]
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 13:14:38 2008''
-
 
+
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 04:36:47 2008''
+

Revision as of 10:14, 4 May 2008

Template:STRUCTURE 2pjl

Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism


Overview

Inverse agonists of the constitutively active human estrogen-related receptor alpha (ERRalpha, NR3B1) are of potential interest for several disease indications (e.g. breast cancer, metabolic diseases, or osteoporosis). ERRalpha is constitutively active, because its ligand binding pocket (LBP) is practically filled with side chains (in particular with Phe(328), which is replaced by Ala in ERRbeta and ERRgamma). We present here the crystal structure of the ligand binding domain of ERRalpha (containing the mutation C325S) in complex with the inverse agonist cyclohexylmethyl-(1-p-tolyl-1H-indol-3-ylmethyl)-amine (compound 1a), to a resolution of 2.3A(.) The structure reveals the dramatic multiple conformational changes in the LBP, which create the necessary space for the ligand. As a consequence of the new side chain conformation of Phe(328) (on helix H3), Phe(510)(H12) has to move away, and thus the activation helix H12 is displaced from its agonist position. This is a novel mechanism of H12 inactivation, different from ERRgamma, estrogen receptor (ER) alpha, and ERbeta. H12 binds (with a surprising binding mode) in the coactivator groove of its ligand binding domain, at a similar place as a coactivator peptide. This is in contrast to ERRgamma but resembles the situation for ERalpha (raloxifene or 4-hydroxytamoxifen complexes). Our results explain the novel molecular mechanism of an inverse agonist for ERRalpha and provide the basis for rational drug design to obtain isotype-specific inverse agonists of this potential new drug target. Despite a practically filled LBP, the finding that a suitable ligand can induce an opening of the cavity also has broad implications for other orphan nuclear hormone receptors (e.g. the NGFI-B subfamily).

About this Structure

2PJL is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism., Kallen J, Lattmann R, Beerli R, Blechschmidt A, Blommers MJ, Geiser M, Ottl J, Schlaeppi JM, Strauss A, Fournier B, J Biol Chem. 2007 Aug 10;282(32):23231-9. Epub 2007 Jun 6. PMID:17556356 Page seeded by OCA on Sun May 4 13:14:38 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools